Compound: suc-LLVY-AMC  
Compound: ac-PAL-AMC  
ConcentrationOfCompound: 0.1 mM suc-LLVY-AMC  
ConcentrationOfCompound: 0.1 mM ac-PAL-AMC  
Compound: MG132 proteasome inhibitor  
ConcentrationOfCompound: 0.04 mM MG132 proteasome inhibitor  
NumberOfTechnicalReplicates: four replicates  
Instrument: Typhoon-9410 laser flatbed scanner (GE Healthcare, USA)  
Time: 3.5 h  
Treatment: IFNγ  
ConcentrationOfCompound: 250 U/ml IFNγ  
Time: 48 h  
BiologicalReplicate: Three different experimental replicates  
Instrument: BD LSR II flow cytometer (BD Biosciences)  
Instrument: UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)  
IonizationType: electrospray  
Instrument: Q-Exactive-Plus (Thermo Fisher Scientific)  
GradientTime: 2 h  
FlowRateChromatogram: 0.15 µl/min  
FragmentationMethod: higher-energy collisional dissociation (HCD)  
CollisionEnergy: 25%  
CleavageAgent: unspecific  
Modification: N-terminal acetylation (42.010565 Da)  
Modification: methionine oxidation (15.994915 Da)  
SyntheticPeptide: All synthetic peptides  
Compound: candidate peptides  
ConcentrationOfCompound: 10 μM  
Time: 2 h  
Temperature: 37 °C  
NumberOfTechnicalReplicates: triplicates  
Time: overnight incubation  
BiologicalReplicate: three experimental replicates per each cell line and each condition  
NumberOfBiologicalReplicates: three biological replicates  
Time: 8 h  
Time: 12 h